Can Teva Pharmaceutical's Dividend Even Survive?

Several big-pharma stocks boast high dividend yields. None of them, though, come close to the 7.5% yield that Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) has recently claimed. Note the use of the past tense, though.

Teva slashed its dividend payment by 75% in August. With the massive dividend cut, Teva's yield will be close to 2%. Teva also lost around 60% of its market cap as a result of this cut, along with announcing a dismal outlook for the full year. Considering the challenges the company faces, can Teva's dividend even survive?

Image source: Getty Images.

Source: Fool.com